Multiplexing allows quantifying multiple analytes in a single step, providing advantages over individual testing through shorter processing time, lower sample volume, and reduced cost per test. Currently, flow cytometry is the gold standard for biomedical multiplexing, but requires technical training, extensive data processing, and expensive operational and capital costs. To solve this challenge, we designed digital barcoded particles and a microfluidic architecture for multiplexed analyte quantification. In this work, we simulate and model non-fluorescence-based microfluidic impedance detection with a single excitation and detection scheme using barcoded polymer microparticles. Our barcoded particles can be designed with specific coding regions and generate numerous distinct patterns enabling digital barcoding. We found that signals based on adhered microsphere position and relative orientation were evaluated and separated based on their associated electrical signatures and had a 7 µm microsphere limit of detection. Our proposed microfluidic system can enumerate micronsized spheres in a single assay using barcoded particles of various configurations. As representation of blood cells, the microsphere concentrations may provide useful information on disease onset and progression. Such sensors may be used for diagnostic and management of common critical care diseases like sepsis, acute kidney injury, urinary tract infections, and HIV/AIDS. Whole blood samples provide imperative data useful for healthy monitoring and understanding disease progression for individuals in critical care settings. Each cell type within the blood has unique properties and methods of isolation, including their relative concentration. Currently, as disease onset occurs, a Complete Blood Cell count (CBC) is often the first step for evaluating a patient's status 1. However, the CBC denies the whole story, as different cellular behaviors, organelle or membrane properties, and mechanical responses by the cells are significantly better indicators for accurate disease determination 2,3. More specialized, multiplexed techniques targeting these blood cell biomarkers may be the key for robust and expedient diagnosis. Most diagnostic equipment requires large blood volumes to measure each targeted analyte separately. In these cases, properties of the blood biomarkers may change and will not satisfy test requirements, burdening both patients of compromised function and healthcare providers conducting the blood extractions 4. While gathering information on more analytes provides more accurate diagnostics, usually experiment complexity and data analysis increases alongside it. As a solution. a multiplexing quantification approach for proteins, nucleic acid sequences, or cytokines overcomes such issues by detecting each biomarker with the same source and sample volume. These abilities enable multiplexing to obtain high density information in minimal time along with low sample volume and less cost 5. To increase multiplexing solutions for biomedical diagno...